four — World Parkinson Congress Blog

Thinking Outside the Box: Beyond the Conventional Effects of Alpha-Synuclein

by Tiago Fleming Outeiro, PhD

Clinical ScienceTiago Fleming Outiero, PhDApril 6, 2020Parkinson's, Protein, fourComment

The Promise of New Technologies in Research

by Christopher G. Sinon, PhD and Stella M. Papa, MD

COVID-19, Anxiety, and Parkinson's: Staying Healthy in These Unusual Times

by Elizabeth "Eli" Pollard

Comprehensive LivingEli PollardMarch 23, 2020Parkinson, COVID-19, anxiety, virus, four, corona virusComment

Onsens and Other Kyoto Musings

by Binit B. Shah MD

Clinical ScienceBinit B. Shah MDMarch 16, 2020World Parkinson Congress, Kyoto, fourComment

Can we use drugs that Modulate the Renin-Angiotensin system to treat Parkinson's disease?

by Santiago Perez Lloret, MD, PhD, Matilde Otero-Losada, PhD, Lucas Udovin, PhD Francisco Capani, MD, PhD

Going against the Grain

by Suketu M. Khandhar, MD

Clinical ScienceSuketu M. Khandhar, MDFebruary 10, 2020Parkinson, fourComment

Why dyskinesias are a research priority in PD

by M. Angela Cenci Nilsson, MD, PhD

Clinical ScienceAngela Cenci NilssonFebruary 3, 2020research, Dyskinesia, fourComment

To tell or not to tell… Talking to children and grandchildren about Parkinson’s disease

by Elaine Book MSW, RSW

Clinical ScienceElaine Book MSW, RSWJanuary 27, 2020parkinsons, children, fourComment

Palliative (And End of Life) Care

by Victor M McConvey, RN, MACN

Clinical ScienceVictor McConveyJanuary 21, 2020parkinsons, Palliative Care, fourComment

Parkinson's disease in the Asia-Pacific region

by Shen-Yang Lim, MD, FRACP

Clinical ScienceShen-Yang Lim, MD FRACPJanuary 13, 2020parkinsons, asia, pacific, fourComment

Speech Therapy: You regained It, don’t forget to maintain It!

by Jennifer Cody, MS, CCC-SLP

Disease Modifying Trials

by Simon Lewis, MB, BCh, BSc, MD

Clinical ScienceSimon LewisDecember 11, 2019Parkinson's, Clinical Trials, Disease Progression, study, four Comment

Getting a grip on anxiety in PD

by Roseanne D. Dobkin, PhD and Lauren St. Hill

Clinical ScienceGuest UserNovember 25, 2019four, anxiety, Parkinson's Comments

Interpersonal, Intrapersonal, and Organizational Intersections: A Socio-Ecological Discussion of Adapted Tango Dance for People with Parkinson’s Disease

by Madeleine E. Hackney, PhD with Allison Bay, MPH

Clinical ScienceGuest UserNovember 15, 2019four, danceComment

Perspectives on the future of technologies in the care of Parkinson’s disease

by Walter Maetzler, MD and Alberto J Espay, MD

Image courtesy of Neurogeriatrics Kiel

Widening the Arms of the PD Community

by Karen Raphael, PhD

Advocacy, Living with Parkinson'sKaren Raphael, Ph.DNovember 4, 2019four, parkinsons, advocacy Comment

Looking behind the masked face... Depression in Parkinson's disease

by Murat Emre, M.D.

Clinical ScienceMurat Emre, M.D.October 31, 2019parkinsons, Parkinson, Depression, four Comment

A is for Apathy: What I wish I had been told about Parkinson’s disease

by Omotola Thomas, MSc

Advocacy, Living with Parkinson'sOmotola Thomas, MScOctober 25, 2019four Comments

A Journey Through a Thousand Gates

by Nancy Peate, MLS

Living with Parkinson'sGuest UserOctober 18, 2019four, wpc2019, Kyoto, AdvocacyComment

Good Communication: The Foundation of Connection and Understanding

by Julie H. Carter RN, MN, ANP

Living with Parkinson'sJulie Carter RN, MN, ANPOctober 14, 2019four, Communication, parkinsonsComment